Syngenta’s $10 bln Shanghai IPO to fund development and acquisitions

HomeStock

Syngenta’s $10 bln Shanghai IPO to fund development and acquisitions


By Meg Shen and John Revill

HONG KONG/ZURICH, July 2 (Reuters)Syngenta Group will use the proceeds from its anticipated $10 billion preliminary public providing (IPO) to fund inside development and an acquisition spree to snare extra of the $100 billion marketplace for seeds and sprays, the agrichemical big mentioned on Friday.

The corporate’s prospectus to listing on Shanghai’s Nasdaq-style STAR Market was posted on-line by the Shanghai Inventory Alternate on Friday, confirming particulars reported this week by Reuters after the applying was filed on Wednesday.

“Syngenta Group will broaden and renovate its manufacturing facility and implement strategic acquisition to satisfy rising market wants,” the corporate mentioned within the doc.

The Shanghai Inventory Alternate submitting confirmed Syngenta’s utility to listing on the STAR Market had been accepted and the corporate plans to concern as much as 2.79 billion shares.

Syngenta’s IPO nonetheless requires the approval of the Shanghai Inventory Alternate and registration with the China Securities Regulatory Fee.

The flotation, set to be the world’s greatest this 12 months, will worth the maker of pesticides and seeds primarily based in Basel, Switzerland, at about $60 billion together with debt, or $50 billion with out, sources have instructed Reuters.

The float is anticipated to be greater than video-sharing platform Kuaishou Know-how’s 1024.HK $6.2 billion Hong Kong IPO. It is going to doubtless be the two-year-old STAR board’s greatest – a significant increase after the 11th-hour scrapping of Ant Group’s blockbuster itemizing final 12 months as a result of regulatory hassle.

The submitting means the flotation is prone to happen by the tip by 2021, mentioned the sources, who weren’t authorised to talk to media and declined to be recognized.

A secondary itemizing for Syngenta can also be being thought-about that might happen lower than a 12 months after its debut, with exchanges in Zurich, London and New York among the many choices being examined, the folks mentioned.

Proceeds will fund acquisitions, together with offers already introduced to purchase Yangnong Agrochemical and Valagro, the submitting mentioned.

Money raised may even be used on different tasks akin to superior agricultural know-how analysis, manufacturing enlargement, and upgrading and sustaining its amenities.

Funds may even be used to broaden additional its fashionable agricultural service platform – which trains farmers in China – and to repay long-term debt, it mentioned.

The Swiss seeds and crop safety big was purchased in 2017 for $43 billion by ChemChina, which was folded into Sinochem Holdings Corp this 12 months.

The acquisition stays China’s greatest takeover of a overseas firm and is aimed toward utilizing Syngenta’s top-tier chemical compounds and patent-protected seeds to drastically enhance home agricultural output.

Since being taken over, Syngenta has been merged with Israeli agrochemical agency ADAMA and the fertiliser and seed enterprise of Sinochem.

Syngenta, the world’s No.1 crop safety maker and No. three seed provider, competes with Germany’s BASF BASFn.DE, Bayer BAYGn.DE and U.S. agrochemicals firm Corteva CTVA.N within the speeds and sprays market.

The corporate employs 49,000 folks globally and generated gross sales of $23.1 billion in 2020. Its greatest markets are america and Brazil, whereas it’s rising quickly in China.

Syngenta reported first-quarter gross sales of $7.1 billion, 20% increased year-on-year, with earnings earlier than curiosity, tax, depreciation and amortisation rising 19% to $1.5 billion.

Web revenue rose 72% within the first quarter, the prospectus mentioned.

($1 = 6.4705 Chinese language yuan renminbi)

(Reporting by John Revill in Zurich, Meg Shen in Hong Kong, Yimin Shen in Shanghai, Colin Qian, Dominque Patton and Shivani Singh in Beijing; Enhancing by David Clarke and William Mallard)

(([email protected]; +41 58306 7022; Reuters Messaging: [email protected]))

The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.



www.nasdaq.com